AXSOME THERAPEUTICS INC's ticker is AXSM and the CUSIP is 05464T104. A total of 228 filers reported holding AXSOME THERAPEUTICS INC in Q3 2023. The put-call ratio across all filers is 0.64 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $6,762,626 | +96.5% | 96,761 | +116.9% | 0.02% | +21.4% |
| Q4 2022 | $3,441,232 | -41.8% | 44,616 | -66.4% | 0.01% | -53.3% |
| Q3 2022 | $5,916,000 | +1743.0% | 132,593 | +1480.2% | 0.03% | +1400.0% |
| Q2 2022 | $321,000 | -9.3% | 8,391 | -21.8% | 0.00% | +100.0% |
| Q3 2021 | $354,000 | -76.1% | 10,730 | -51.2% | 0.00% | -83.3% |
| Q2 2021 | $1,484,000 | +109.3% | 22,003 | +75.6% | 0.01% | +50.0% |
| Q1 2021 | $709,000 | -33.9% | 12,529 | -31.3% | 0.00% | -85.2% |
| Q1 2020 | $1,073,000 | +0.8% | 18,234 | +77.1% | 0.03% | +350.0% |
| Q4 2019 | $1,064,000 | +9.6% | 10,297 | -72.7% | 0.01% | -33.3% |
| Q2 2019 | $971,000 | +451.7% | 37,706 | +20.1% | 0.01% | +200.0% |
| Q4 2017 | $176,000 | -5.4% | 31,400 | -6.5% | 0.00% | -25.0% |
| Q3 2017 | $186,000 | – | 33,600 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ALETHEA CAPITAL MANAGEMENT, LLC | 1,132,645 | $37,332,000 | 32.86% |
| MORGAN JESS S & CO INC | 113,430 | $3,739,000 | 2.47% |
| Fairmount Funds Management LLC | 187,598 | $6,183,000 | 2.25% |
| IRIDIAN ASSET MANAGEMENT LLC/CT | 1,423,653 | $46,924,000 | 1.43% |
| WMS Partners, LLC | 250,000 | $8,240,000 | 1.21% |
| Beck Bode, LLC | 102,127 | $3,366,000 | 0.94% |
| RTW INVESTMENTS, LP | 1,616,497 | $53,280,000 | 0.80% |
| MPM BioImpact LLC | 110,155 | $3,631,000 | 0.56% |
| Endurant Capital Management LP | 52,048 | $1,716,000 | 0.39% |
| Bellevue Group AG | 752,945 | $24,817,000 | 0.25% |